YTHDF2 and neoplasm: This is consistent with previous findings on m6A-binding protein YTHDF2 and modulating the location and stability of EGFR mRNA at its 3’UTR site, enhancing the degradation of the EGFR mRNA, and playing an anti-tumor role in hepatocellular carcinoma (Yu et al., 2019).